Eisai Co., Ltd. (4523.T) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Nikkei 225

Eisai Co., Ltd. (4523.T) closed at JPY 4,868.00 on 2026-10-15, a change of +11 % over the past year, with a market capitalization of JPY 1.39T.

Eisai Co., Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Eisai Co., Ltd. key figures

Previous close

JPY 4,868.00 (2026-10-15)

1-year change

+11 %

Market cap

JPY 1.39T

Enterprise value

JPY 1.36T

P/E ratio (trailing)

34.76

P/E ratio (forward)

24.35

EPS (trailing)

141.91

EPS (forward)

202.57

PEG ratio

26.43

Price to book

1.53

Revenue growth

15.6 %

Earnings growth

26 %

Dividend per share (trailing)

160.00

Short ratio

n/a

Employees

10,543

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Eisai Co., Ltd.

Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments. It offers Lenvima, a multi-kinase inhibitor which is involved in tumor angiogenesis or tumor malignancy; LEQEMBI, a humanized IgG1 monoclonal antibody against amyloid-beta (Aß) protofibrils; and Dayvigo, a novel small molecule compound. The company also provides prescription drugs; and over-the-counter drugs, as well as focuses on neurology and oncology, and other therapeutic areas. It operates in Europe, the Middle East, Africa, Russia, Oceania, the Americas, China, East Asia, the Global South, and internationally. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Eisai Co., Ltd. and compare it with other stocks.